Clinical Trial Update: Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs) [NA]

View source ↗

Summary

A clinical trial evaluating repeat monthly Alexandrite laser treatment for neurofibromatosis type 1-associated cutaneous neurofibromas is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Neurofibromatosis 1 (NF1), Neurofibromatosis Type I | NA | Status: SUSPENDED